ReShape Lifesciences Balance Sheet Health
Financial Health criteria checks 6/6
ReShape Lifesciences has a total shareholder equity of $1.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $5.6M and $4.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$743.00k |
| Equity | US$1.49m |
| Total liabilities | US$4.13m |
| Total assets | US$5.62m |
Recent financial health updates
Recent updates
It's A Story Of Risk Vs Reward With ReShape Lifesciences Inc. (NASDAQ:RSLS)
Apr 18
ReShape wins FDA clearance for device used in weight loss surgery
Aug 10Analysts Have Lowered Expectations For ReShape Lifesciences Inc. (NASDAQ:RSLS) After Its Latest Results
Mar 31Health Check: How Prudently Does ReShape Lifesciences (NASDAQ:RSLS) Use Debt?
Dec 09Does ReShape Lifesciences (NASDAQ:RSLS) Have A Healthy Balance Sheet?
Aug 24Financial Position Analysis
Short Term Liabilities: RSLS's short term assets ($5.3M) exceed its short term liabilities ($4.0M).
Long Term Liabilities: RSLS's short term assets ($5.3M) exceed its long term liabilities ($103.0K).
Debt to Equity History and Analysis
Debt Level: RSLS is debt free.
Reducing Debt: RSLS had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RSLS has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: RSLS is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.